Rational combinations of immunotherapy with radiotherapy in ovarian cancer
Except for its use in palliative care, radiotherapy has been largely abandoned in the
management of ovarian cancer because of the recognised efficacy and lower toxicity of …
management of ovarian cancer because of the recognised efficacy and lower toxicity of …
Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells
D Heylmann, F Rödel, T Kindler, B Kaina - Biochimica et Biophysica Acta …, 2014 - Elsevier
Immunodeficiency is a severe side effect of radiation therapy, notably at high radiation
doses. It may also impact healthy individuals exposed to environmental ionizing radiation …
doses. It may also impact healthy individuals exposed to environmental ionizing radiation …
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer
K Lim, W Small Jr, L Portelance, C Creutzberg… - International Journal of …, 2011 - Elsevier
PURPOSE: Accurate target definition is vitally important for definitive treatment of cervix
cancer with intensity-modulated radiotherapy (IMRT), yet a definition of clinical target volume …
cancer with intensity-modulated radiotherapy (IMRT), yet a definition of clinical target volume …
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical …
W Small Jr, LK Mell, P Anderson, C Creutzberg… - International Journal of …, 2008 - Elsevier
PURPOSE: To develop an atlas of the clinical target volume (CTV) definitions for
postoperative radiotherapy of endometrial and cervical cancer to be used for planning pelvic …
postoperative radiotherapy of endometrial and cervical cancer to be used for planning pelvic …
Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer
AH Klopp, J Moughan, L Portelance, BE Miller… - International Journal of …, 2013 - Elsevier
PURPOSE: Intensity modulated radiation therapy (IMRT), compared with conventional 4-
field treatment, can reduce the volume of bone marrow irradiated. Pelvic bone marrow …
field treatment, can reduce the volume of bone marrow irradiated. Pelvic bone marrow …
Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an international multicenter phase II clinical trial …
LK Mell, I Sirák, L Wei, R Tarnawski… - International Journal of …, 2017 - Elsevier
Purpose To test the hypothesis that intensity modulated radiation therapy (IMRT) reduces
acute hematologic and gastrointestinal (GI) toxicity for patients with locoregionally advanced …
acute hematologic and gastrointestinal (GI) toxicity for patients with locoregionally advanced …
Complications of pelvic radiation in patients treated for gynecologic malignancies
AN Viswanathan, LJ Lee, JR Eswara, NS Horowitz… - Cancer, 2014 - Wiley Online Library
Radiation therapy is a critical treatment modality in the management of patients with
gynecologic tumors. New highly conformal external‐beam and brachytherapy techniques …
gynecologic tumors. New highly conformal external‐beam and brachytherapy techniques …
Dose–volume effects for normal tissues in external radiotherapy: pelvis
C Fiorino, R Valdagni, T Rancati… - Radiotherapy and …, 2009 - Elsevier
A great deal of quantitative information regarding the dose–volume relationships of pelvic
organs at risk has been collected and analysed over the last 10 years. The need to improve …
organs at risk has been collected and analysed over the last 10 years. The need to improve …
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience
Purpose To report a multicenter experience treating anal canal cancer patients with
concurrent chemotherapy and intensity-modulated radiation therapy (IMRT). Patients and …
concurrent chemotherapy and intensity-modulated radiation therapy (IMRT). Patients and …
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity …
PURPOSE: To test the hypothesis that the volume of pelvic bone marrow (PBM) receiving 10
and 20 Gy or more (PBM-V10 and PBM-V20) is associated with acute hematologic toxicity …
and 20 Gy or more (PBM-V10 and PBM-V20) is associated with acute hematologic toxicity …